Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197547 · ClinicalTrials.gov registry record · NA
Registry Study of Genesys HTA for Treatment of Menorrhagia
A NA study, sponsored by Minerva Surgical.
- Completed
- Registry status
- NA
- Development phase
- 1,014
- Enrollment target
NCT01197547: Completed NA study, sponsored by Minerva Surgical.
NCT01197547 is a NA study that has completed, run by Minerva Surgical. The registered enrollment target is 1,014 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01197547, a NA study, has completed, sponsored by Minerva Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,014 participants
- Enrollment target
Study Summary
This is a clinical registry of an FDA approved device system called the Genesys Hydro ThermAblatorTM (HTA) system (Boston Scientific). The HTA system's intended use is to be inserted, by a trained physician, into the uterus, where it will fill and circulate fluid that is warm enough to change the characteristics of the uterine lining. This is done with the anticipated result of improving menstrual bleeding symptoms. The purpose of this FDA-mandated registry is to obtain clinical experience on the use the Genesys HTA™ system, under normal clinical conditions, and document its safety and technical reliability.
Interventions
- DEVICE Genesys HTA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,014 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-08 |
| Phase | NA |
What the finished NCT01197547 record still lists
NCT01197547 is an interventional study that assigns participants to a tested intervention. Its 1,014 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 1 intervention - of which Genesys HTA is the first listed.
NCT01197547 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01197547 about?
NCT01197547 is a clinical study titled "Registry Study of Genesys HTA for Treatment of Menorrhagia". This is a clinical registry of an FDA approved device system called the Genesys Hydro ThermAblatorTM (HTA) system (Boston Scientific). The HTA system's intended use is to be inserted, by a trained physician, into the uterus, where it will fill and circulate fluid that is warm enough to change the ch...
What is the current status of trial NCT01197547?
This trial is currently completed. It is a NA study. The enrollment target is 1,014 participants. The study started on 2010-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01197547?
The interventions under investigation include: Genesys HTA (DEVICE).
Who is sponsoring clinical trial NCT01197547?
This trial is sponsored by Minerva Surgical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01197547's enrollment target sits among peer trials
1,014 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia